Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Category: Doctors & Hospitals

Public Health Experts: America has an Eating, Drinking and Lack of Exercise Problem

Posted on June 21, 2022 by Devon Herrick

America has a collective drinking problem. And an eating problem. This is all made worse by Americans propensity to sit at home watching TV or playing video games. A recent study has found that deaths from alcoholic cirrhosis have more than tripled in 20 years. In 1999 alcoholic cirrhosis killed 6,007 Americans or about 3.3 per 100,000 adults. By 2019 the death rate had risen to 10.6 per 100,000. Keep in mind this is only for adults aged 25 to 85+

+

Do Higher Priced Hospitals Deliver Higher Quality Care?

Posted on June 8, 2022 by John C. Goodman

This NBER Working Paper says it depends on whether there is competition.

In markets with more hospital competition, going to higher-priced hospitals raises spending by approximately 53 percent and lowers mortality by 47 percent. By contrast, in concentrated hospital markets receiving care from a high-priced hospital also raises spending by 54 percent, but has no impact on patient outcomes.

And the higher spending in competitive markets is worth it:

Such hospitals spend approximately $1 million per life saved. Assuming that the individuals in the research sample live for another nine years, this is cost effective relative to the Environmental Protection Agency’s $8.7 million benchmark estimate of the value of a statistical life.

Unfortunately, the trend in the overall market is for more concentration and less competition.

+

Why “Testing to Treat” for Covid Isn’t Working

Posted on May 21, 2022May 24, 2022 by John C. Goodman

This is Larry Kotlikoff at Forbes:

We now have wonderful new drugs to treat COVID. Paxlovid, produced by Pfizer, is an example. But half of these medications aren’t being prescribed. Indeed, many go to waste, sitting on the shelves of pharmacies until their expiration dates.

+

Open Borders and Lax Drug Policies Are Contributing to Fatal Drug Overdoses

Posted on May 19, 2022 by John C. Goodman

Most of the additional fatal overdoses post-Covid involve methamphetamine and fentanyl made in Mexico, China and India. For each overdose death, more than 100 people struggle with debilitating addictions to these dangerous substances.

Coincident with policy changes advertised as civil-rights progress, the comparatively low drug-overdose rate for blacks began to accelerate. It reached the white rate by 2019 and then surged past it during the pandemic to reach 43 annually per 100,000 of the black population by last September.

Joe Grogan and Casey Mulligan in the WSJ.

+
  • Previous
  • 1
  • …
  • 216
  • 217
  • 218
  • 219
  • 220
  • 221
  • 222
  • …
  • 225
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 49 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom